The role of nanotechnology-based approaches for clinical infectious diseases and public health
Given the high incidence of infection and the growing resistance of bacterial and viral infections to the traditional antiseptic, the need for novel antiseptics is critical. Therefore, novel approaches are urgently required to reduce the activity of bacterial and viral infections. Nanotechnology is...
Main Authors: | Xuefang Chen, Jinfang Xu, Bangju Ji, Xingliang Fang, Ketao Jin, Jun Qian |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-04-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fbioe.2023.1146252/full |
Similar Items
-
Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01) -
Insight into 2019 novel coronavirus — An updated interim review and lessons from SARS-CoV and MERS-CoV
by: Mingxuan Xie, et al.
Published: (2020-05-01) -
Nano‐therapeutic strategies to target coronavirus
by: Mohd Ahmar Rauf, et al.
Published: (2021-06-01) -
SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
by: Hatem A. Elshabrawy
Published: (2020-06-01) -
Challenges and future directions of potential natural products leads against 2019-nCoV outbreak
by: Meirambek Ospanov, et al.
Published: (2020-12-01)